检索结果-南通市图书馆

Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第36期18卷 5065-5071页

作者： Giuseppe Merra Giovanni Gasbarrini Lucrezia Laterza Marco Pizzoferrato Andrea Poscia Franco Scaldaferri Vincenzo Arena francesca fiore Achille Cittadini Alessandro Sgambato Francesco Franceschi Antonio Gasbarrini Emergency Department Catholic University of Sacred Heart00168 RomeItaly Medical Research Foundation and nonprofit organization 40123 BolognaItaly Department of Internal Medicine and Gastroenterology Catholic University of Sacred Heart00168 RomeItaly Institute of Hygiene Catholic University of Sacred Heart00168 RomeItaly Institute of Pathology Catholic University of Sacred Heart00168 RomeItaly Department of Internal Medicine and Geriatry Catholic University of Sacred Heart00168 RomeItaly Institute of General Pathology Catholic University of Sacred Heart00168 RomeItaly

AIM:To assess clinical and endoscopic response to propionyl-L-carnitine hydrochloride(PLC) in colonic inflammatory bowel ***:Patients suffering from mild to moderate ulcerative colitis(UC) or Crohn's disease(CD) colitis,with disease activity index(DAI) between 3 and 10 and under stable therapy with oral aminosalicylates,mercaptopurine or azathioprine,for at least 8 wk prior to baseline assessments,were considered suitable for *** patients were enrolled to assume PLC 2 g/d(two active tablets twice daily) ***-endoscopic and histological activity were assessed by DAI and histological index(HI),respectively,following a colonoscopy performed immediately before and after 4 wk *** response was defined as a lowering of at least 3 points in DAI and clinical remission as a DAI score ≤ *** response was defined as an improvement of HI of at least 1 *** used median values for the *** pre-and post-treatment were analyzed by Wilcoxon signed rank ***:All patients enrolled completed the *** patient,despite medical advice,took deflazacort 5 d before follow-up colonoscopy *** side effects were reported by patients during the *** treatment,71%(SE 12%) of patients achieved clinical response,while 64%(SE 13%) obtained *** UC from CD patients,we observed a clinical response in 60%(SE 16%) and 100%,*** 60%(SE 16%) of UC patients and 75%(SE 25%) of CD patients were in clinical remission after *** median DAI was 7 [interquartile range(IQR):4-8] before treatment and decreased to 2(IQR:1-3)(P < 0.01) after *** patients with UC showed a significant reduction of DAI,from a median 6.5(IQR:4-9) before treatment to 2(IQR:1-3) after treatment(P < 0.01).Conversely,in CD patients,although displaying a clear reduction of DAI from 7(IQR:5.5-7.5) before therapy to 1.5(IQR:0.5-2.5) after therapy,differences observed were not sign

关键词： PropionyI-L-carnitine Ulcerative colitis Crohn's disease Inflammatory bowel disease therapy PropionyI-L-carnitine hydrochloride

Pain management in acute musculoskeletal injury: Effect of opioid vs nonopioid medications

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Orthopedics 2024年第9期15卷 882-890页

作者： Marco fiore Luigi Aurelio Nasto Eleni McCaffery Fannia Barletta Angela Visconti francesca Gargano Enrico Pola Maria Caterina Pace Department of Women Child and General and Specialized SurgeryUniversity of Campania“Luigi Vanvitelli”Naples 80138Italy Department of Orthopaedics University of Campania“Luigi Vanvitelli”Naples 80138Italy Department of Emergency Medicine New York Presbyterian-Brooklyn Methodist HospitalNew YorkNY 11215United States Department of Anesthesia and Intensive Care “San Carlo”HospitalPotenza 85100Italy Department of Anaesthesia “San Giuliano”HospitalGiugliano 80014Italy Unit of Anesthesia and Intensive Care The Fondazione Policlinico Universitario Campus Bio-MedicoRome 00128Italy

BACKGROUND The use of opioids for pain is linked to an increased risk of developing opioid use disorder,and has resulted in the emergence of the opioid crisis over the last few *** The systematic review question is“How does the use of opioid medications in pain management,compared with non-opioid medications,affect pain intensity over the short,intermediate,and long-term in adults with acute traumatic pain?”.METHODS The protocol was prospectively registered on the International Prospective Re-gister of Systematic Reviews:*** and Google Scholar were electronically searched for controlled peer-reviewed studies published in full,with the PICO framework:P:Adult patients with traumatic injuries,I:Opioid medications,C:Non-opioid medi-cations,O:A minimum clinically important difference(MCID)in *** After full-text screening,we included 14 studies in the qualitative *** these 14 studies,12 were rando-mized clinical trials(RCTs)and 2 were pseudo-RCTs with a total of 2347 patients *** was heteroge-neity in both medication utilized and outcome in these studies;only two studies were homogeneous regarding the type of study conducted,the opioid used,its comparator,and the outcome *** MCID was evaluated in 8 studies,while in 6 studies,any measured pain reduction was considered as an *** 11 cases,the setting of care was the Emergency Department;in 2 cases,care occurred out-of-hospital;and in one case,the setting was not *** included studies were found to have a low-moderate risk of *** Non-opioids can be considered an alternative to opioids for short-term pain management of acute musculoskeletal *** ketamine may cause more adverse events than other routes of administration.

关键词： Acute musculoskeletal injury Acute traumatic pain Non-opioid analgesia Non-opioid pain control Opioid-sparing analgesia Opioid crisis Opioid disorder Systematic review

Antimicrobial approach of abdominal post-surgical infections

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastrointestinal Surgery 2023年第12期15卷 2674-2692页

作者： Marco fiore Antonio Corrente Sveva Di Franco Aniello Alfieri Maria Caterina Pace francesca Martora Stephen Petrou Claudio Mauriello Sebastiano Leone Department of Women Child and General and Specialized SurgeryUniversity of Campania“Luigi Vanvitelli”Naples 80138Italy Unit of Virology and Microbiology “Umberto I”HospitalNocera Inferiore 84018Italy Department of Emergency Medicine University of California San FranciscoSan FranciscoCA 94143United States Department of General Surgery “Santa Maria delle Grazie”HospitalPozzuoli 80078Italy Division of Infectious Diseases “San Giuseppe Moscati”HospitalAvellino 83100Italy

Abdominal surgical site infections(SSIs)are infections that occur after abdominal *** can be superficial,involving the skin tissue only,or more profound,involving deeper skin tissues including organs and implanted ***,SSIs are large global health problem with an incidence that varies significantly depending on the United Nations’Human Development *** purpose of this review is to provide a practical update on the latest available literature on SSIs,focusing on causative pathogens and treatment with an overview of the ongoing studies of new therapeutic strategies.

关键词： Surgical site infections Multidrug resistance Carbapenem-resistant Enterobacterales Carbapenem-resistant Klebsiella Abdominal post-operative complications Post-surgical infections

Ultra-subwavelength phase-sensitive Fano-imaging of localized photonic modes

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Light(Science & Applications) 2015年第1期4卷 223-230页

作者： Niccolo Caselli francesca Intonti Federico La China Francesco Riboli Annamaria Gerardino Wei Bao Alexander Weber Bargioni Lianhe Li Edmund H Linfield Francesco Pagliano Andrea fiore Massimo Gurioli European Laboratory for Nonlinear Spectroscopy via Nello Carrara 150019Sesto Fiorentino(FI)Italy Department of Physics University of Florencevia Sansone 150019 Sesto Fiorentino(FI)Italy Department of Physics University of Trentovia Sommarive 1438123Povo(TN)Italy Institute of Photonics and Nanotechnology CNR00156 RomaItaly Molecular Foundry Lawrence Berkeley National LaboratoryBerkeleyCA 94720USA School of Electronic and Electrical Engineering University of LeedsLeeds LS29JTUK COBRA Research Institute Eindhoven University of Technology5600 MB EindhovenThe Netherlands

Photonic and plasmonic devices rely on nanoscale control of the local density of optical states(LDOS)in dielectric and metallic *** tremendous progress in designing and tailoring the electric LDOS of nano-resonators requires an investigation tool that is able to access the detailed features of the optical localized resonant modes with deep-subwavelength spatial *** scenario has motivated the development of different nanoscale imaging ***,we prove that a technique involving the combination of scanning near-field optical microscopy with resonant scattering spectroscopy enables imaging the electric LDOS in nano-resonators with outstanding spatial resolution(λ/19)by means of a pure optical method based on light *** this technique,we investigate the properties of photonic crystal nanocavities,demonstrating that the resonant modes appear as characteristic Fano line shapes,which arise from ***,by monitoring the spatial variation of the Fano line shape,we locally measure the phase modulation of the resonant modes without the need of external heterodyne *** novel,deep-subwavelength imaging method allows us to access both the intensity and the phase modulation of localized electric ***,this technique could be implemented on any type of platform,being particularly appealing for those based on non-optically active material,such as silicon,glass,polymers,or metals.

关键词： nanocavity nanophotonics near-field phase retrieval resonant-scattering

Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae:Etiology and antibiotic treatment

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Hepatology 2020年第12期12卷 1136-1147页

作者： Marco fiore Sveva Di Franco Aniello Alfieri Maria Beatrice Passavanti Maria Caterina Pace Stephen Petrou francesca Martora Sebastiano Leone Department of Women Child and General and Specialized SurgeryUniversity of Campania“Luigi Vanvitelli”Naples 80138Italy Department of Emergency Medicine Good Samaritan Hospital Medical CenterNY 11795United States Department of Experimental Medicine University of Campania“Luigi Vanvitelli”Naples 80138Italy Division of Infectious Diseases “San Giuseppe Moscati”HospitalAvellino 83100Italy

Carbapenem antibiotics were first introduced in the 1980s and have long been considered the most active agents for the treatment of multidrug-resistant gramnegative *** the last decade,carbapenem-resistant Enterobacteriaceae(CRE)have emerged as organisms causing spontaneous bacterial *** caused by CRE have shown a higher mortality rate than those caused by bacteria sensitive to carbapenem *** antibiotic guidelines for the treatment of spontaneous bacterial peritonitis are insufficient,and rapid deescalation of empiric antibiotic treatment is not widely *** review summarizes the molecular characteristics,epidemiology and possible treatment of spontaneous bacterial peritonitis caused by CRE.

关键词： Spontaneous bacterial peritonitis Carbapenem-resistant Enterobacteriaceae Carbapenem-resistant Klebsiella pneumoniae Cirrhosis

Bevacizumab maintenance in metastatic colorectal cancer: How long?

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Clinical Cases 2014年第11期2卷 717-723页

作者： Alfonso De Stefano Roberto Moretto Chiara Alessandra Cella Francesco Jacopo Romano Lucia Raimondo Giovanni fiore francesca Di Pietro Stefano Pepe Sabino De Placido Chiara Carlomagno Department of Clinical Medicine and Surgery School of Medicine University of Naples "Federico II" 80131 Napoli Italy Department of Medicine School of Medicin and Pharmacology University of Salerno 84081 Baronissi (SA)Italy

The management of patients with non-progressive metastatic colorectal cancer after six months of treatment has not yet been codified. The most relevant concerns are the effectiveness of maintenance versus discontinuation, and the tolerability of prolonged treatment. Here we report the case of a 72-year-old man affected by colorectal cancer with lung metastases who achieved a complete response after receiving capecitabine, oxaliplatin and bevacizumab for six months, and bevacizumab alone for six months. Bevacizumab was continued as maintenance regimen for more than three years. It was discontinued because of an arthroplasty. Fifty-eight months after beginning first-line treatment, the patientremains free from relapse. Adverse effects were minimal and easily controlled.

关键词： Metastatic colorectal cancer Bevacizumab Maintenance